PACTR202209551216666

I CAN WAIT: Assessing the effectiveness of using comprehensive sexuality education in improving uptake of HIV testing among adolescent and young people in secondary schools

Impact Research and Development Organization·Not Applicable·Pan Africa Clinical Trials Registry·otherCompleted
Study focus
Intervention type
other
Sponsor & location
Primary sponsor
Impact Research and Development Organization
Funder
Bill and Melinda Gates Foundation
Location
Kenya
Timeline & enrollment
Phase
Not Applicable
Start date
May 01, 2022
End date
Nov 30, 2022
Summary

Kenya is one of the countries in Africa where the HIV/AIDS pandemic still poses huge challenges to social and economic development activities. The Kenya HIV estimates report by National AIDS and Control Council (NACC) indicates that the national HIV prevalence is at 4.9% (Kenya HIV estimates 2018 report); which translates to approximately 1.3 million adults living with HIV in Kenya (KENPHIA 2018). Among those aged 14-24 years, the HIV prevalence among females stood at 1.3%, while that of males was at 2.6% (KARPR 2018). These findings show that the adolescent and young people are more vulnerable to HIV infection. Some of the factors cited as driving the spread of the disease include early sexual debut, inconsistent condom use, lack of knowledge about HIV/AIDS, multiple sexual partners, and transactional sex (WHO 2006). Studies that have examined effects of interventions based on the social cognitive theory indicate that sexual and reproductive behavioral interventions among young people are effective, especially when targeting adolescent and young people before they become sexually active (Maticka-Tyndale et al. 2007). Primary Objective:To assess the effectiveness of using a CSE program to promote uptake of HIV testing among adolescent and young people in secondary schools.Secondary objectives: 1. To assess the effectiveness of using a CSE program in enhancing uptake of HIV testing services among adolescents and young people in secondary schools.2. To assess the acceptability of using a CSE program to promote primary and secondary abstinence among adolescents and young people in secondary schools.3. To measure the prevalence of self-reported risky sexual behaviours and practices among adolescents and young people in secondary schools.4. To assess the feasibility of using a CSE program to promote primary and secondary abstinence among adolescents and young people in secondary schools to inform future scale up with an aim to inform future scale-up

ICD-10 classifications
Certain infectious and parasitic diseasesInfestation, unspecifiedOther specified infestationsOther infestationsSequelae of infectious and parasitic diseases
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR202209551216666
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR202209551216666 through Pure Global AI's free database. This Not Applicable trial is sponsored by Impact Research and Development Organization and is currently Completed. The study focuses on Infections and Infestations; Infections and Infestations.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.